Sunder Biomedical Tech. Co., Ltd.
TWO: 4115.TWO0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Taipei Exchange
- Sector
- Healthcare
- Industry
- Medical - Instruments & Supplies
- CEO
- Yuanqiong Yu
- Employees
- 346
- Headquarters
- Taichung, Taiwan
- IPO year
- 2022
- Market cap
- NT$630.0M
- Website
- https://www.sunder.com.tw
Loading 4115…
Loading profile data…Frequently asked questions about 4115
What does Sunder Biomedical Tech. Co., Ltd. (4115.TWO) do?
Sunder Biomedical Tech. Co., Ltd. manufactures and sells medical devices. It offers protective goggles, melt blown nonwoven fabric and mask, suction irrigation set, smoke filter, endo bag, blood line set for hemodialysis, A.V. Fistula needle set, I.V. administration, extension tube, volume control I.V. administration set, surgical tubing set, co...
Where does 4115.TWO trade?
Sunder Biomedical Tech. Co., Ltd. (4115.TWO) trades on the Taipei Exchange.
What sector is 4115.TWO in?
Sunder Biomedical Tech. Co., Ltd. (4115.TWO) operates in the Healthcare sector, specifically in the Medical - Instruments & Supplies industry.
Who is the CEO of Sunder Biomedical Tech. Co., Ltd.?
Yuanqiong Yu is the chief executive officer of Sunder Biomedical Tech. Co., Ltd. (4115.TWO).
Where is Sunder Biomedical Tech. Co., Ltd. headquartered?
Sunder Biomedical Tech. Co., Ltd. is headquartered in Taiwan.
Does 4115.TWO pay a dividend?
Sunder Biomedical Tech. Co., Ltd. (4115.TWO) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did 4115.TWO go public?
Sunder Biomedical Tech. Co., Ltd. (4115.TWO) completed its initial public offering in 2022.